Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Unexo Life Sciences Private Limited
WARNING LETTER
•Unexo Life Sciences Private Limited•May 14, 2024

Unexo Life Sciences Private Limited – FDA Warning Letter, May 14, 2024

Record Details

The FDA issued a Warning Letter to Unexo Life Sciences, Private Limited, following an inspection from May 1-14, 2024, identifying significant CGMP violations, rendering their drug products adulterated.

Key violations include: 1. **Quality Control Unit Failures (21 CFR 211.22):** The firm's quality control unit failed to ensure CGMP compliance and data reliability. * **Incomplete Batch Records (21 CFR 211.188):** Torn and missing batch production records were found, and executive management admitted to retrospectively preparing records for U.S. market products. The firm's response was inadequate, lacking detail on detecting non-contemporaneous records and a rationale for only destroying select batches. * **Incomplete Laboratory Records (21 CFR 211.194(a)):** Raw data for product testing, including assay and peel strength, was missing for released drug products. The firm's response was inadequate, lacking a detailed investigation plan for incomplete records and sufficient detail on data integrity detection. * **Inadequate Computer System Controls (21 CFR 211.68(b)):** A QC analyst could manipulate results, dates, and images on COAs from third-party labs. The firm's response was inadequate, failing to detail how appropriate controls and user privileges would be implemented.

Company
Unexo Life Sciences Private Limited
Inspection date
May 14, 2024
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · 0bdc6157-bfd2-4bad-b0ac-c9ecd5aa968e

Violation Codes10
21 CFR 21021 CFR 21121 CFR 211.2221 CFR 211.18821 CFR 211.194(a)21 CFR 211.68(b)21 CFR 211.67(a)FD&C Act 501(a)(2)(B)FD&C Act 801(a)(3)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for Unexo Life Sciences Private Limited
  • 483 - 2024-05-14May 14, 2024

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Unexo Life Sciences Private Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.